AEYE is up +392.76% since Feb ’24 pick Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of 1312.HK
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Tongfang Kontafarma Holdings Limited stock price ended at HK$0.0380 on Thursday, after losing 0%.
(Updated on May 23, 2024)

Buy candidate since May 21, 2024 Loss -2.56% PDF

No changes to the price of Tongfang Kontafarma Holdings Limited stock on the last trading day (Thursday, 23rd May 2024). During the last trading day the stock fluctuated 0% from a day low at HK$0.0380 to a day high of HK$0.0380. The price has fallen in 4 of the last 10 days but is still up by 8.57% over the past 2 weeks.

The stockis at the upper part of a very wide and horizontal trend and normally this may pose a good selling opportunity but a break-up through the top trend line at HK$0.0390 will give a strong buy signal and a trend shift could be expected. Given the current horizontal trend, you can expect Tongfang Kontafarma Holdings Limited stock with a 90% probability to be traded between HK$0.0283 and HK$0.0393 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

1312.HK Signals & Forecast

The Tongfang Kontafarma Holdings Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at HK$0.0367 and HK$0.0342. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, May 22, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. The stock had a Golden Star Signal on Wednesday, April 17, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Wednesday, April 17, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Tongfang Kontafarma Holdings Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at HK$0.0360 and HK$0.0350. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Tongfang Kontafarma Holdings Limited finds support just below today's level at HK$0.0360. If this is broken, then the next support from accumulated volume will be at HK$0.0350 and HK$0.0320.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved HK$0 between high and low, or 0%. For the last week the stock has had daily average volatility of 6.11%

Our recommended stop-loss: HK$0.0358 (-5.72%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (1312.HK) For The Upcoming Trading Day Of Friday 24th

For the upcoming trading day on Friday, 24th we expect Tongfang Kontafarma Holdings Limited to open at HK$0.0380, and during the day (based on 14 day Average True Range), to move between HK$0.0348 and HK$0.0412, which gives a possible trading interval of +/-HK$0.0032 (+/-8.51%) up or down from last closing price. If Tongfang Kontafarma Holdings Limited takes out the full calculated possible swing range there will be an estimated 17.02% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at HK$0.0390 (2.63%) than the support at HK$0.0360 (5.26%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Tongfang Kontafarma Holdings Limited stock A Buy?

Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Tongfang Kontafarma Holdings Limited stock to perform well in the short-term period.

Current score: 2.716 Buy Candidate Unchanged

Predicted Opening Price for Tongfang Kontafarma Holdings Limited of Friday, May 24, 2024

Fair opening price May 24, 2024 Current price
HK$0.0380 ( 0%) HK$0.0380

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for 1312.HK

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.0380 .
R2 0.0380 .
R1 0.0380 .
Current price: 0.0380
Support S1 0.0380 .
S2 0.0380 .
S3 0.0380 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0.0390 2.63 %
Current price 0.0380
Support S1 0.0360 -5.26%
S2 0.0350 -7.89%
S3 0.0320 -15.79%

1312 Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Mar 15, 2013 May 27, 2013 Jun 13, 2013 HK$0.0040 3.08%
2 Mar 25, 2012 May 28, 2012 Jun 13, 2012 HK$0.0040 2.82%

FAQ

What is the symbol for Tongfang Kontafarma Holdings Limited Stock and on which exchange is it traded?
The symbol for Tongfang Kontafarma Holdings Limited is 1312.HK and it is traded on the HKEX (Hong Kong Stock Exchange).

Should I buy or sell Tongfang Kontafarma Holdings Limited Stock?
Several short-term signals are positive and we conclude that the current level may hold a buying opportunity, as there is a fair chance for Tongfang Kontafarma Holdings Limited stock to perform well in the short-term period.

How to buy Tongfang Kontafarma Holdings Limited Stock?
Tongfang Kontafarma Holdings Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Tongfang Kontafarma Holdings Limited Stock.

What's the current price of Tongfang Kontafarma Holdings Limited Stock?
As of the end of day on the May 23, 2024, the price of an Tongfang Kontafarma Holdings Limited (1312.HK) share was HK$0.0380.

What is the 52-week high and low for Tongfang Kontafarma Holdings Limited Stock?
The 52-week high for Tongfang Kontafarma Holdings Limited Stock is HK$0.0480 and the 52-week low is HK$0.0260.

What is the market capitalization of Tongfang Kontafarma Holdings Limited Stock?
As of the May 23, 2024, the market capitalization of Tongfang Kontafarma Holdings Limited is 211.991M.

When is the next earnings date for Tongfang Kontafarma Holdings Limited?
The upcoming earnings date for Tongfang Kontafarma Holdings Limited is Aug 28, 2024.
Click to get the best stock tips daily for free!

About Tongfang Kontafarma Holdings Limited

Tongfang Kontafarma Holdings Limited, an investment holding company, engages in the manufacture and sale of prescription drugs and laboratory related products in Mainland China, Singapore, Taiwan, and the United States. The company operates in Pharmaceutical Business and Fitness Business segments. It also offers chemical drugs and prescribed traditional Chinese medicines; operates fitness centers; operates in the franchise business; and provides ... 1312.HK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT